BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9025271)

  • 1. Kinetic analysis of the cis-diamminedichloroplatinum(II)--cysteine reaction: implications to the extent of platinum--DNA binding.
    Bose RN; Ghosh SK; Moghaddas S
    J Inorg Biochem; 1997 Feb; 65(3):199-205. PubMed ID: 9025271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG).
    Lempers EL; Bloemink MJ; Brouwer J; Kidani Y; Reedijk J
    J Inorg Biochem; 1990 Sep; 40(1):23-35. PubMed ID: 2283508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.
    Dedon PC; Borch RF
    Biochem Pharmacol; 1987 Jun; 36(12):1955-64. PubMed ID: 2954556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactions of cisplatin hydrolytes with methionine, cysteine, and plasma ultrafiltrate studied by a combination of HPLC and NMR techniques.
    el-Khateeb M; Appleton TG; Gahan LR; Charles BG; Berners-Price SJ; Bolton AM
    J Inorg Biochem; 1999 Oct; 77(1-2):13-21. PubMed ID: 10626348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A complete kinetic study of GG versus AG plantination suggests that the doubly aquated derivatives of cisplatin are the actual DNA binding species.
    Legendre F; Bas V; Kozelka J; Chottard JC
    Chemistry; 2000 Jun; 6(11):2002-10. PubMed ID: 10894399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unwinding of zinc finger domain of DNA polymerase I by cis-diamminedichloroplatinum(II).
    Maurmann L; Bose RN
    Dalton Trans; 2010 Sep; 39(34):7968-79. PubMed ID: 20668765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
    Bierbach U; Sabat M; Farrell N
    Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elusive intermediates in cisplatin reaction with target amino acids: Platinum(II)-cysteine complexes assayed by IR ion spectroscopy and DFT calculations.
    Corinti D; Paciotti R; Coletti C; Re N; Chiavarino B; Crestoni ME; Fornarini S
    J Inorg Biochem; 2022 Dec; 237():112017. PubMed ID: 36209532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents.
    Hollis LS; Sundquist WI; Burstyn JN; Heiger-Bernays WJ; Bellon SF; Ahmed KJ; Amundsen AR; Stern EW; Lippard SJ
    Cancer Res; 1991 Apr; 51(7):1866-75. PubMed ID: 2004370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.
    Comess KM; Burstyn JN; Essigmann JM; Lippard SJ
    Biochemistry; 1992 Apr; 31(16):3975-90. PubMed ID: 1314653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC determination of binding of cisplatin to DNA in the presence of biological thiols: implications of dominant platinum-thiol binding to its anticancer action.
    Volckova E; Dudones LP; Bose RN
    Pharm Res; 2002 Feb; 19(2):124-31. PubMed ID: 11883638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs.
    Jansen BA; Brouwer J; Reedijk J
    J Inorg Biochem; 2002 Apr; 89(3-4):197-202. PubMed ID: 12062123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A circular dichroism study of DNA.platinum complexes. Differentiation between monofunctional, cis-bidentate and trans-bidentate platinum fixation on a series of DNAs.
    Macquet JP; Butour JL
    Eur J Biochem; 1978 Feb; 83(2):375-85. PubMed ID: 631125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphonato complexes of platinum(II): kinetics of formation and phosphorus-31 NMR characterization studies.
    Slavin LL; Bose RN
    J Inorg Biochem; 1990 Dec; 40(4):339-47. PubMed ID: 2150856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
    Knox RJ; Friedlos F; Lydall DA; Roberts JJ
    Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel dinuclear platinum(II) complexes containing mixed nitrogen-sulfur donor ligands.
    Hochreuther S; Puchta R; van Eldik R
    Inorg Chem; 2011 Dec; 50(24):12747-61. PubMed ID: 22085155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactions of Dinuclear Platinum(II) Complexes with Peptides.
    Rajković S; Živković MD; Djuran MI
    Curr Protein Pept Sci; 2016; 17(2):95-105. PubMed ID: 26521953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monofunctional platinum amine complexes destabilize DNA significantly.
    Bauer C; Peleg-Shulman T; Gibson D; Wang AH
    Eur J Biochem; 1998 Sep; 256(2):253-60. PubMed ID: 9760162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thioethers on DNA platination by trans-platinum complexes.
    Li C; Huang R; Ding Y; Sletten E; Arnesano F; Losacco M; Natile G; Liu Y
    Inorg Chem; 2011 Sep; 50(17):8168-76. PubMed ID: 21812429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cis-Platinum induced distortions in DNA. Conformational analysis of d(GpCpG) and cis-pt(NH3)2[d(GpCpG)], studied by 500-MHz NMR.
    den Hartog JH; Altona C; van Boom JH; Marcelis AT; van der Marel GA; Rinkel LJ; Wille-Hazeleger G; Reedijk J
    Eur J Biochem; 1983 Aug; 134(3):485-95. PubMed ID: 6684039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.